Literature DB >> 24511153

Influence of GSTT1 Genetic Polymorphisms on Arsenic Metabolism.

Molly L Kile1, E Andres Houseman1, Quazi Quamruzzaman2, Mahmuder Rahman2, Golam Mahiuddin2, Golam Mostofa2, Yu-Mei Hsueh3, David C Christiani4.   

Abstract

A repeated measures study was conducted in Pabna, Bangladesh to investigate factors that influence biomarkers of arsenic exposure. Drinking water arsenic concentrations were measured by inductively-coupled plasma mass spectrometry (ICP-MS) and urinary arsenic species [arsenite (As3), arsenate (As5), monomethylarsonic acid (MMA) and dimethylarsinic acid (DMA)] were detected using High Performance Liquid Chromatography (HPLC) and Hydride Generated Atomic Absorption Spectrometry (HGAAS). Linear mixed effects models with random intercepts were used to evaluate the effects of arsenic contaminated drinking water, genetic polymorphisms in glutathione-S-transferase (GSTT1 and GSTM1) on total urinary arsenic, primary methylation index [MMA/(As3+As5)], secondary methylation index (DMA/MMA), and total methylation index [(MMA+DMA)/(As3+As5)]. Drinking water arsenic concentrations were positively associated with total urinary arsenic concentrations and total methylation index. A significant gene-environment interaction was observed between urinary arsenic exposure in drinking water GSTT1 but not GSTM1 where GSTT1 null individuals had a slightly higher excretion rate of arsenic compared to GSTT1 wildtypes after adjusting for other factors. Additionally, individuals with GSTT1 null genotypes had a higher primary methylation index and lower secondary methylation index compared to GSTT1 wildtype after adjusting for other factors. This data suggests that GSTT1 contributes to the observed variability in arsenic metabolism. Since individuals with a higher primary methylation index and lower secondary methylation index are more susceptible to arsenic related disease, these results suggest that GSTT1 null individuals may be more susceptible to arsenic-related toxicity. No significant associations were observed between GSTM1 and any of the arsenic methylation indices.

Entities:  

Keywords:  Arsenic; Bangladesh; Environmental health; GSTT1; Gene environment interaction; Methylation; Urinary arsenic

Year:  2013        PMID: 24511153      PMCID: PMC3916182     

Source DB:  PubMed          Journal:  J Indian Soc Agric Stat        ISSN: 0019-6363


  48 in total

1.  Millions more at risk of arsenic poisoning than previously thought.

Authors:  Sanjay Kumar
Journal:  BMJ       Date:  2003-03-01

2.  Assessment of exposure to arsenic among smelter workers: a five-year follow-up.

Authors:  B J Lagerkvist; B Zetterlund
Journal:  Am J Ind Med       Date:  1994-04       Impact factor: 2.214

3.  Urinary excretion of inorganic arsenic and its metabolites after repeated ingestion of sodium metaarsenite by volunteers.

Authors:  J P Buchet; R Lauwerys; H Roels
Journal:  Int Arch Occup Environ Health       Date:  1981       Impact factor: 3.015

4.  Human retention studies with 74As.

Authors:  C Pomroy; S M Charbonneau; R S McCullough; G K Tam
Journal:  Toxicol Appl Pharmacol       Date:  1980-05       Impact factor: 4.219

Review 5.  Methylation of inorganic arsenic in different mammalian species and population groups.

Authors:  M Vahter
Journal:  Sci Prog       Date:  1999       Impact factor: 2.774

6.  GSTO and AS3MT genetic polymorphisms and differences in urinary arsenic concentrations among residents in Bangladesh.

Authors:  Ema G Rodrigues; Molly Kile; Elaine Hoffman; Quazi Quamruzzaman; Mahmuder Rahman; Golam Mahiuddin; Yumei Hsueh; David C Christiani
Journal:  Biomarkers       Date:  2012-02-18       Impact factor: 2.658

7.  Human monomethylarsonic acid (MMA(V)) reductase is a member of the glutathione-S-transferase superfamily.

Authors:  R A Zakharyan; A Sampayo-Reyes; S M Healy; G Tsaprailis; P G Board; D C Liebler; H V Aposhian
Journal:  Chem Res Toxicol       Date:  2001-08       Impact factor: 3.739

8.  Elucidating the pathway for arsenic methylation.

Authors:  David J Thomas; Stephen B Waters; Miroslav Styblo
Journal:  Toxicol Appl Pharmacol       Date:  2004-08-01       Impact factor: 4.219

9.  Human studies do not support the methylation threshold hypothesis for the toxicity of inorganic arsenic.

Authors:  C Hopenhayn-Rich; A H Smith; H M Goeden
Journal:  Environ Res       Date:  1993-02       Impact factor: 6.498

10.  Determinants of inorganic arsenic methylation capability among residents of the Lanyang Basin, Taiwan: arsenic and selenium exposure and alcohol consumption.

Authors:  Yu-Mei Hsueh; Yih-Fu Ko; Yung-Kay Huang; Hui-Wen Chen; Hung-Yi Chiou; Ya-Li Huang; Mo-Hsiung Yang; Chien-Jen Chen
Journal:  Toxicol Lett       Date:  2003-01-31       Impact factor: 4.372

View more
  4 in total

1.  Associations between the polymorphisms of GSTT1, GSTM1 and methylation of arsenic in the residents exposed to low-level arsenic in drinking water in China.

Authors:  Jinyou Yang; Li Yan; Min Zhang; Yijun Wang; Chun Wang; Quanyong Xiang
Journal:  J Hum Genet       Date:  2015-04-16       Impact factor: 3.172

2.  Arsenic and subclinical vascular damage in a sample of Italian young adults: a cross-sectional analysis.

Authors:  Francesco Stea; Francesco Faita; Andrea Borghini; Francesca Faita; Fabrizio Bianchi; Elisa Bustaffa; Fabrizio Minichilli; Maria Grazia Andreassi; Rosa Sicari
Journal:  Environ Sci Pollut Res Int       Date:  2016-07-23       Impact factor: 4.223

3.  Urinary Arsenic in Human Samples from Areas Characterized by Natural or Anthropogenic Pollution in Italy.

Authors:  Fabrizio Minichilli; Fabrizio Bianchi; Anna Maria Ronchi; Francesca Gorini; Elisa Bustaffa
Journal:  Int J Environ Res Public Health       Date:  2018-02-09       Impact factor: 3.390

4.  Gene-environment interaction and maternal arsenic methylation efficiency during pregnancy.

Authors:  Shangzhi Gao; Md Golam Mostofa; Quazi Quamruzzaman; Mahmudur Rahman; Mohammad Rahman; Li Su; Yu-Mei Hsueh; Marc Weisskopf; Brent Coull; David C Christiani
Journal:  Environ Int       Date:  2019-01-28       Impact factor: 9.621

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.